Valuation Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. 2026-09-04			5-day change	1st Jan Change
1,585.00 ^ARS	+1.60%		+0.96%	-19.75%

Aug. 06	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 10	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	9,327	17,927	31,412	56,405	144,949	159,484
Change	-	92.21%	75.23%	79.56%	156.98%	10.03%
Enterprise Value (EV) ¹	10,516	22,242	50,309	149,735	278,596	390,519
Change	-	111.5%	126.19%	197.63%	86.06%	40.17%
P/E	19.2x	30.3x	193x	-5.2x	6.08x	51.6x
PBR	2.76x	3.39x	3.11x	2.5x	2.25x	1.74x
PEG	-	1.4x	-2.7x	0x	-0x	-0.6x
Capitalization / Revenue	1.51x	1.08x	1.7x	1.45x	1.58x	1.26x
EV / Revenue	1.7x	1.34x	2.72x	3.84x	3.04x	3.08x
EV / EBITDA	6.66x	8.95x	15.1x	23.2x	15.3x	11.8x
EV / EBIT	7.07x	9.58x	16.9x	28.3x	17.9x	13.1x
EV / FCF	-27.8x	-9.98x	-5.19x	58x	-49x	-7.4x
FCF Yield	-3.59%	-10%	-19.3%	1.72%	-2.04%	-13.5%
Dividend per Share ²	0.5547	-	-	-	26.89	-
Rate of return	0.48%	-	-	-	1.5%	-
EPS ²	6.02	7.32	2.02	-134.4	295.3	38.24
Distribution rate	9.21%	-	-	-	9.11%	-
Net sales ¹	6,181	16,616	18,470	39,028	91,794	126,726
EBITDA ¹	1,578	2,486	3,326	6,441	18,249	32,999
EBIT ¹	1,487	2,322	2,982	5,299	15,565	29,906
Net income ¹	486.2	591.5	163.4	-10,851	23,845	3,088
Net Debt ¹	1,189	4,315	18,897	93,330	133,647	231,035
Reference price ²	115.50	222.00	389.00	698.50	1,795.00	1,975.00
Nbr of stocks (in thousands)	80,751	80,751	80,751	80,751	80,751	80,751
Announcement Date	3/10/21	3/9/22	3/9/23	3/11/24	3/7/25	3/6/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIOS RICHMOND S.A.C.I.F.	-	-	-	-	84.93M
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,024B
JOHNSON & JOHNSON	30.62x	-	-	1.95%	663B
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	453B
ROCHE HOLDING AG	19.89x	4.73x	11.71x	2.8%	352B
NOVARTIS AG	22.72x	5.84x	14.51x	2.7%	304B
ASTRAZENECA PLC	20.87x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.66x	7.14x	13.15x	2.31%	236B
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	206B
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	187B
Average	17.16x	6.62x	15.96x	2.34%	367.85B
Weighted average by Cap.	24.05x	7.99x	17.80x	1.95%